NEW YORK, March 06, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Netflix, Inc. (“Netflix”) (NASDAQ:NFLX) securities between July 22, 2014 and October 15, 2014.
Click here to learn about the case: http://www.wongesq.com/pslra/netflix-inc. There is no cost or obligation to you.
The complaint alleges that Company insiders knew from prior experience and analyses that price increases could have a substantial negative impact on subscriber growth; yet on July 21, 2014, CEO Reed Hastings and CFO David Wells told the market that the impact of the price increase had been “minimal” and “nominal.” The complaint alleges, however, that just three months later, on October 15, 2014, Defendants revealed that subscriber growth numbers were so low that the Company was forced to slash its projected earnings by nearly half, suggesting that “[as] best we can tell, the primary cause is the slightly higher price we now have compared to a year ago.”
If you suffered a loss in Netflix you have until May 1, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/netflix-inc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 



